Semaglutide may safeguard the heart even without significant weight loss. A new study led by a researcher at University College London (UCL) suggests that the anti-obesity drug semaglutide may reduce the risk of heart attacks and other serious cardiac events even when people lose little or no weight while taking it. According to the researchers, […]
Source link